Filter by
Selections
October 16, 2012
Arrowhead Research Receives Notice of Patent Allowance for New Formulation of DPC siRNA Delivery System Showing 500-Fold Increase in Potency
Read MoreSeptember 5, 2012
Arrowhead to Present at Rodman and Renshaw Annual Global Investment Conference
Read MoreAugust 30, 2012
Arrowhead Completes Enrollment in Phase 1b Trial of RNAi Drug Candidate CALAA-01
Read MoreAugust 13, 2012
Arrowhead Raises $6.2 Million through Registered Direct Offering of Common Stock and Warrants
Read MoreAugust 9, 2012
Arrowhead Research to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference
Read MoreJuly 11, 2012
Arrowhead Announces Dosing of First Patient with Anti-Obesity Treatment Adipotide® in a Phase 1 Clinical Trial
Read MoreJune 26, 2012